In This Article:
As global markets navigate through a mix of challenges and opportunities, Sweden's market remains a focal point for investors looking for growth. Amidst this backdrop, companies with high insider ownership in Sweden could offer unique advantages, as such ownership often aligns with long-term commitment to company success in unpredictable times.
Top 10 Growth Companies With High Insider Ownership In Sweden
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 24.8% |
Biovica International (OM:BIOVIC B) | 18.7% | 73.8% |
Magle Chemoswed Holding (OM:MAGLE) | 14.9% | 72.2% |
Sileon (OM:SILEON) | 20.3% | 109.3% |
KebNi (OM:KEBNI B) | 37.8% | 90.4% |
Yubico (OM:YUBICO) | 37.5% | 43.8% |
BioArctic (OM:BIOA B) | 34% | 50.9% |
Calliditas Therapeutics (OM:CALTX) | 11.6% | 52.9% |
edyoutec (NGM:EDYOU) | 14.6% | 63.1% |
SaveLend Group (OM:YIELD) | 23.3% | 103.4% |
Underneath we present a selection of stocks filtered out by our screen.
BioArctic
Simply Wall St Growth Rating: ★★★★★★
Overview: BioArctic AB (ticker: OM:BIOA B) is a Swedish company focused on developing biological drugs for central nervous system disorders, with a market capitalization of SEK 20.67 billion.
Operations: The company generates revenue primarily from its biotechnology segment, totaling SEK 252.21 million.
Insider Ownership: 34%
Earnings Growth Forecast: 50.9% p.a.
BioArctic, a Swedish biopharmaceutical company, is poised for significant growth with its Alzheimer's treatment, Leqembi, recently approved in Hong Kong and other major markets. Despite a recent quarterly loss (SEK 57.56 million), the firm's revenue is expected to grow by 41% annually. Analysts predict a substantial rise in stock price (57.4%) and BioArctic trades at 67.2% below estimated fair value, indicating potential upside. However, insider transactions have not shown substantial buying activity recently.
-
Click to explore a detailed breakdown of our findings in BioArctic's earnings growth report.
-
Our valuation report unveils the possibility BioArctic's shares may be trading at a discount.
Sectra
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Sectra AB (publ) specializes in medical IT and cybersecurity solutions across Sweden, the United Kingdom, the Netherlands, and other European countries, with a market capitalization of SEK 47.13 billion.
Operations: Sectra's revenue is primarily generated from its Imaging IT Solutions segment, which earned SEK 2.55 billion, followed by Secure Communications at SEK 367.35 million and Business Innovation contributing SEK 89.87 million.